Treatment of muscle‐invasive and advanced bladder cancer in 2020 von Patel, Vaibhav G., Oh, William K., Galsky, Matthew D.

Volltext

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial von Sharma, Padmanee, Prof, Retz, Margitta, Prof, Siefker-Radtke, Arlene, MD, Baron, Ari, MD, Necchi, Andrea, MD, Bedke, Jens, Prof, Plimack, Elizabeth R, MD, Vaena, Daniel, MD, Grimm, Marc-Oliver, Prof, Bracarda, Sergio, MD, Arranz, José Ángel, MD, Pal, Sumanta, MD, Ohyama, Chikara, Prof, Saci, Abdel, PhD, Qu, Xiaotao, PhD, Lambert, Alexandre, PhD, Krishnan, Suba, MD, Azrilevich, Alex, PharmD, Galsky, Matthew D, Prof

Volltext

A Systematic Review of Strategies to Prevent Cisplatin‐Induced Nephrotoxicity von Crona, Daniel J., Faso, Aimee, Nishijima, Tomohiro F., McGraw, Kathleen A., Galsky, Matthew D., Milowsky, Matthew I.

Volltext

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy von Rosenberg, Jonathan E, O'Donnell, Peter H, Balar, Arjun V, McGregor, Bradley A, Heath, Elisabeth I, Yu, Evan Y, Galsky, Matthew D, Hahn, Noah M, Gartner, Elaina M, Pinelli, Juan M, Liang, Shang-Ying, Melhem-Bertrandt, Amal, Petrylak, Daniel P

Volltext

The impact of the globalization of cancer clinical trials on the enrollment of Black patients von Tharakan, Serena, Zhong, Xiaobo, Galsky, Matthew D.

Volltext

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma von Bajorin, Dean F, Witjes, J. Alfred, Gschwend, Jürgen E, Schenker, Michael, Valderrama, Begoña P, Tomita, Yoshihiko, Bamias, Aristotelis, Lebret, Thierry, Shariat, Shahrokh F, Park, Se Hoon, Ye, Dingwei, Agerbaek, Mads, Enting, Deborah, McDermott, Ray, Gajate, Pablo, Peer, Avivit, Milowsky, Matthew I, Nosov, Alexander, Neif Antonio, João, Tupikowski, Krzysztof, Toms, Laurence, Fischer, Bruce S, Qureshi, Anila, Collette, Sandra, Unsal-Kacmaz, Keziban, Broughton, Edward, Zardavas, Dimitrios, Koon, Henry B, Galsky, Matthew D

Volltext

All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase von Sangodkar, Jaya, Farrington, Caroline C., McClinch, Kimberly, Galsky, Matthew D., Kastrinsky, David B., Narla, Goutham

Volltext

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer von Wang, Li, Saci, Abdel, Szabo, Peter M., Chasalow, Scott D., Castillo-Martin, Mireia, Domingo-Domenech, Josep, Siefker-Radtke, Arlene, Sharma, Padmanee, Sfakianos, John P., Gong, Yixuan, Dominguez-Andres, Ana, Oh, William K., Mulholland, David, Azrilevich, Alex, Hu, Liangyuan, Cordon-Cardo, Carlos, Salmon, Hélène, Bhardwaj, Nina, Zhu, Jun, Galsky, Matthew D.

Volltext

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial von Sharma, Padmanee, Pachynski, Russell K., Narayan, Vivek, Fléchon, Aude, Gravis, Gwenaelle, Galsky, Matthew D., Mahammedi, Hakim, Patnaik, Akash, Subudhi, Sumit K., Ciprotti, Marika, Simsek, Burcin, Saci, Abdel, Hu, Yanhua, Han, G. Celine, Fizazi, Karim

Volltext

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial von Galsky, Matthew D, Arija, José Ángel Arranz, Bamias, Aristotelis, Davis, Ian D, De Santis, Maria, Kikuchi, Eiji, Garcia-del-Muro, Xavier, De Giorgi, Ugo, Mencinger, Marina, Izumi, Kouji, Panni, Stefano, Gumus, Mahmut, Özgüroğlu, Mustafa, Kalebasty, Arash Rezazadeh, Park, Se Hoon, Alekseev, Boris, Schutz, Fabio A, Li, Jian-Ri, Ye, Dingwei, Vogelzang, Nicholas J, Bernhard, Sandrine, Tayama, Darren, Mariathasan, Sanjeev, Mecke, Almut, Thåström, AnnChristine, Grande, Enrique

Volltext

Immune link to failure of cancer treatment von Galsky, Matthew D

Volltext

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma von van der Heijden, Michiel S., Sonpavde, Guru, Powles, Thomas, Necchi, Andrea, Burotto, Mauricio, Schenker, Michael, Sade, Juan Pablo, Bamias, Aristotelis, Beuzeboc, Philippe, Bedke, Jens, Oldenburg, Jan, Chatta, Gurkamal, Ürün, Yüksel, Ye, Dingwei, He, Zhisong, Valderrama, Begoña P., Ku, Ja Hyeon, Tomita, Yoshihiko, Filian, Jeiry, Wang, Lily, Purcea, Daniela, Patel, Miraj Y., Nasroulah, Federico, Galsky, Matthew D.

Volltext

Resistance to prostate-cancer treatment is driven by immune cells von Galsky, Matthew D.

Volltext

Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275 von Galsky, Matthew D., Saci, Abdel, Szabo, Peter M., Han, G. Celine, Grossfeld, Gary, Collette, Sandra, Siefker-Radtke, Arlene, Necchi, Andrea, Sharma, Padmanee

Volltext

Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer von Galsky, Matthew D, Stensland, Kristian D, Moshier, Erin, Sfakianos, John P, McBride, Russell B, Tsao, Che-Kai, Casey, Martin, Boffetta, Paolo, Oh, William K, Mazumdar, Madhu, Wisnivesky, Juan P

Volltext

PD-1 inhibitors for urothelial cancer: combination or sequential therapy? – Authors' reply von Galsky, Matthew D, Grande, Enrique

Volltext

Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy von GALSKY, Matthew D, HAHN, Noah M, BELLMUNT, Joaquim, ROSENBERG, Jonathan, SONPAVDE, Guru, HUTSON, Thomas, OH, William K, DREICER, Robert, VOGELZANG, Nicholas, STERNBERG, Cora N, BAJORIN, Dean F

Volltext

The effect of adding immune checkpoint inhibitors on the risk of pneumonitis for solid tumours: a meta-analysis of phase III randomised controlled trials von Fujiwara, Yu, Horita, Nobuyuki, Namkoong, Ho, Galsky, Matthew D.

Volltext

Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials von Fujiwara, Yu, Horita, Nobuyuki, Harrington, Matthew, Namkoong, Ho, Miyashita, Hirotaka, Galsky, Matthew D.

Volltext

Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer von Ben-David, Reuben, Galsky, Matthew D., Sfakianos, John P.

Volltext